Drug factory · FDA FEI 3014028588
Aurolife Pharma LLC
Unit-II, 2929 Weck Drive, Durham, NC, United States
Problems found, fixed voluntarily at FDA's last inspection, Aug 26, 2022.
Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.
1 drug inspection on record since 2022: 0 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.
What it does, for whom
| Drug | Role | For | NDC |
|---|---|---|---|
| Beclomethasone | Makes it and tests it | Aurolife Pharma LLC | 13107-230, 13107-231 |
| Diclofenac | Makes it and tests it | Aurolife Pharma LLC, Northstar Rx LLC. | 13107-269, 72603-207 |
FDA inspection history
| Ended | Result | Program | Problems noted |
|---|---|---|---|
| Aug 26, 2022 | Problems found, fixed voluntarily | Drug Quality Assurance | — |
Registered with FDA for: analysis; manufacture; pack; relabel; repack.